Clinigen Group

Executive Summary

Clinigen Group is a UK-based global pharmaceutical services company founded in 2010. It operates three core service lines: supplying drugs for clinical trials, managing access to unlicensed medicines for named patients, and commercial supply of licensed pharmaceuticals. By bridging gaps in traditional supply chains, Clinigen enables timely medicine availability for patients worldwide. The company serves a diverse client base including pharmaceutical firms, biotech companies, and healthcare providers. With its integrated platform, Clinigen is well-positioned to benefit from increasing complexity in drug access and global clinical trial activity.

Upcoming Catalysts (preview)

• TBDPotential expansion into emerging markets for managed access services60% success
• TBDNew strategic partnerships with biopharma companies for clinical trial supply70% success
• TBDRegulatory developments favoring unlicensed medicine access pathways50% success